Literature DB >> 16895752

Double umbilical cord blood transplantation.

Navneet S Majhail1, Claudio G Brunstein, John E Wagner.   

Abstract

Unrelated umbilical cord blood (UCB) is an alternative donor source for allogeneic haematopoietic cell transplantation and, compared with unrelated donor bone marrow, has the advantages of rapid availability, greater tolerance of HLA disparity and lower incidence of severe graft-versus-host disease. Graft cell dose is an important determinant of haematopoietic recovery and overall outcome following UCB transplantation, and the limited cell dose of single UCB units has been a major barrier to its more widespread use. Transplantation with two unrelated UCB units is feasible, safe and effective and can overcome the limitation of cell dose of single UCB units.

Entities:  

Mesh：

Year:  2006        PMID： 16895752     DOI： 10.1016/j.coi.2006.07.015

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN： 0952-7915            Impact factor:   7.486


  38 in total

Review 1.  Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance.

Authors:  Young-June Kim; Hal E Broxmeyer
Journal:  Crit Rev Oncol Hematol       Date:  2010-08-19       Impact factor: 6.312

2.  Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing.

Authors:  Krishna V Komanduri; Lisa S St John; Marcos de Lima; John McMannis; Steven Rosinski; Ian McNiece; Susan G Bryan; Indreshpal Kaur; Sean Martin; Eric D Wieder; Laura Worth; Laurence J N Cooper; Demetrios Petropoulos; Jeffrey J Molldrem; Richard E Champlin; Elizabeth J Shpall
Journal:  Blood       Date:  2007-08-01       Impact factor: 22.113

Review 3.  Lymphoid reconstruction and vaccines.

Authors:  Ronald E Gress; Krishna V Komanduri; Hermann Einsele; Laurence J N Cooper
Journal:  Biol Blood Marrow Transplant       Date:  2007-01       Impact factor: 5.742

4.  Preinfusion variables predict the predominant unit in the setting of reduced-intensity double cord blood transplantation.

Authors:  R L Haspel; G Kao; B Y Yeap; C Cutler; R J Soiffer; E P Alyea; V T Ho; J Koreth; B R Dey; S L McAfee; E C Attar; T Spitzer; J H Antin; K K Ballen
Journal:  Bone Marrow Transplant       Date:  2007-11-26       Impact factor: 5.483

5.  Human term placenta as a source of hematopoietic cells.

Authors:  Vladimir Serikov; Catherine Hounshell; Sandra Larkin; William Green; Hirokazu Ikeda; Mark C Walters; Frans A Kuypers
Journal:  Exp Biol Med (Maywood)       Date:  2009-05-08

6.  Stem cell through present and future.

Authors:  Vijay K Sharma; Utpal K Singh; Rajniti Prasad; Sophie Fletcher
Journal:  Indian J Pediatr       Date:  2009-04-18       Impact factor: 1.967

7.  Stable mixed double donor chimerism: Absence of war doesn't necessarily mean peace.

Authors:  Jens Gertow; Jonas Mattsson J; Michael Uhlin
Journal:  Chimerism       Date:  2010-10

8.  Double unit cord blood transplantation: Who wins-and why do we care?

Authors:  Jonathan A Gutman; Stanley R Riddell; Suzanne McGoldrick; Colleen Delaney
Journal:  Chimerism       Date:  2010 Jul-Sep

9.  Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors.

Authors:  Margaret L MacMillan; Daniel J Weisdorf; Claudio G Brunstein; Qing Cao; Todd E DeFor; Michael R Verneris; Bruce R Blazar; John E Wagner
Journal:  Blood       Date:  2008-11-07       Impact factor: 22.113

Review 10.  Optimal HLA matching in hematopoietic cell transplantation.

Authors:  Effie W Petersdorf
Journal:  Curr Opin Immunol       Date:  2008-08-08       Impact factor: 7.486
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.